APO Research
Talk to an analyst

APO RESEARCH · REPORT

NAD+ Enhancer

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global NAD+ Enhancer Industry Growth and Trends Forecast to 2032

27 December 2025109 pages

Choose your research edition.

Industry ResearchNAD+ Enhancer Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal NAD+ Enhancer Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal NAD+ Enhancer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NAD+ Enhancer Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal NAD+ Enhancer Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global NAD+ Enhancer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for NAD+ Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for NAD+ Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NAD+ Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NAD+ Enhancer include EffePharm, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), GeneHarbor, NOMON Co., Ltd. (Teijin), Maac10 Formulas, Kingdomway, Herbalmax, Genex Formulas and EZZ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global NAD+ Enhancer market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The NAD+ Enhancer market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global NAD+ Enhancer market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to NAD+ Enhancer.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global NAD+ Enhancer market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

NAD+ Enhancer Market by Company

EffePharm

Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

GeneHarbor

NOMON Co., Ltd. (Teijin)

Maac10 Formulas

Kingdomway

Herbalmax

Genex Formulas

EZZ

Elysium Health

Chromadex

CELFULL

Bontac

NAD+ Enhancer Segment by Type

Content ＜98%

Content ≥98%

NAD+ Enhancer Segment by Application

Health Care Products

ClinicsBeauty Products

Others

NAD+ Enhancer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Enhancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NAD+ Enhancer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Enhancer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of NAD+ Enhancer manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of NAD+ Enhancer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Content ＜98% Table 2. Major Company of Content ≥98% Table 3. Global NAD+ Enhancer Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global NAD+ Enhancer Sales by Type (2021-2026) & (K Units) Table 5. Global NAD+ Enhancer Sales Market Share in Volume by Type (2021-2026) Table 6. Global NAD+ Enhancer Sales by Type (2021-2026) & (US$ Million) Table 7. Global NAD+ Enhancer Sales Market Share in Value by Type (2021-2026) Table 8. Global NAD+ Enhancer Price by Type (2021-2026) & (US$/Unit) Table 9. Global NAD+ Enhancer Sales by Type (2027-2032) & (K Units) Table 10. Global NAD+ Enhancer Sales Market Share in Volume by Type (2027-2032) Table 11. Global NAD+ Enhancer Sales by Type (2027-2032) & (US$ Million) Table 12. Global NAD+ Enhancer Sales Market Share in Value by Type (2027-2032) Table 13. Global NAD+ Enhancer Price by Type (2027-2032) & (US$/Unit) Table 14. North America NAD+ Enhancer Sales by Type (2021-2026) & (K Units) Table 15. North America NAD+ Enhancer Sales by Type (2021-2026) & (US$ Million) Table 16. Europe NAD+ Enhancer Sales by Type (2021-2026) & (K Units) Table 17. Europe NAD+ Enhancer Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific NAD+ Enhancer Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific NAD+ Enhancer Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America NAD+ Enhancer Sales by Type (2021-2026) & (K Units) Table 21. Latin America NAD+ Enhancer Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa NAD+ Enhancer Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa NAD+ Enhancer Sales by Type (2021-2026) & (US$ Million) Table 24. NAD+ Enhancer Industry Trends Table 25. NAD+ Enhancer Industry Drivers Table 26. NAD+ Enhancer Industry Opportunities and Challenges Table 27. NAD+ Enhancer Industry Restraints Table 28. Global NAD+ Enhancer Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global NAD+ Enhancer Revenue Market Share by Company (2021-2026) Table 30. Global NAD+ Enhancer Sales by Company (2021-2026) & (K Units) Table 31. Global NAD+ Enhancer Sales Share by Company (2021-2026) Table 32. Global NAD+ Enhancer Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global NAD+ Enhancer Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global NAD+ Enhancer Major Company Production Sites and Headquarters Table 35. Global NAD+ Enhancer Company, Product Type & Application Table 36. Global NAD+ Enhancer Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global NAD+ Enhancer by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global NAD+ Enhancer Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global NAD+ Enhancer Sales by Region (2021-2026) & (K Units) Table 41. Global NAD+ Enhancer Sales Market Share in Volume by Region (2021-2026) Table 42. Global NAD+ Enhancer Sales by Region (2021-2026) & (US$ Million) Table 43. Global NAD+ Enhancer Sales Market Share in Value by Region (2021-2026) Table 44. Global NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global NAD+ Enhancer Sales by Region (2027-2032) & (K Units) Table 46. Global NAD+ Enhancer Sales Market Share in Volume by Region (2027-2032) Table 47. Global NAD+ Enhancer Sales by Region (2027-2032) & (US$ Million) Table 48. Global NAD+ Enhancer Sales Market Share in Value by Region (2027-2032) Table 49. Global NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global NAD+ Enhancer Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global NAD+ Enhancer Sales by Application (2021-2026) & (K Units) Table 52. Global NAD+ Enhancer Sales Market Share in Volume by Application (2021-2026) Table 53. Global NAD+ Enhancer Sales by Application (2021-2026) & (US$ Million) Table 54. Global NAD+ Enhancer Sales Market Share in Value by Application (2021-2026) Table 55. Global NAD+ Enhancer Price by Application (2021-2026) & (US$/Unit) Table 56. Global NAD+ Enhancer Sales by Application (2027-2032) & (K Units) Table 57. Global NAD+ Enhancer Sales Market Share in Volume by Application (2027-2032) Table 58. Global NAD+ Enhancer Sales by Application (2027-2032) & (US$ Million) Table 59. Global NAD+ Enhancer Sales Market Share in Value by Application (2027-2032) Table 60. Global NAD+ Enhancer Price by Application (2027-2032) & (US$/Unit) Table 61. North America NAD+ Enhancer Sales by Application (2021-2026) & (K Units) Table 62. North America NAD+ Enhancer Sales by Application (2021-2026) & (US$ Million) Table 63. Europe NAD+ Enhancer Sales by Application (2021-2026) & (K Units) Table 64. Europe NAD+ Enhancer Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific NAD+ Enhancer Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific NAD+ Enhancer Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America NAD+ Enhancer Sales by Application (2021-2026) & (K Units) Table 68. Latin America NAD+ Enhancer Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa NAD+ Enhancer Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa NAD+ Enhancer Sales by Application (2021-2026) & (US$ Million) Table 71. EffePharm Company Information Table 72. EffePharm Business Overview Table 73. EffePharm NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. EffePharm NAD+ Enhancer Product Portfolio Table 75. EffePharm Recent Development Table 76. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information Table 77. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview Table 78. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Portfolio Table 80. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Development Table 81. GeneHarbor Company Information Table 82. GeneHarbor Business Overview Table 83. GeneHarbor NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GeneHarbor NAD+ Enhancer Product Portfolio Table 85. GeneHarbor Recent Development Table 86. NOMON Co., Ltd. (Teijin) Company Information Table 87. NOMON Co., Ltd. (Teijin) Business Overview Table 88. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product Portfolio Table 90. NOMON Co., Ltd. (Teijin) Recent Development Table 91. Maac10 Formulas Company Information Table 92. Maac10 Formulas Business Overview Table 93. Maac10 Formulas NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Maac10 Formulas NAD+ Enhancer Product Portfolio Table 95. Maac10 Formulas Recent Development Table 96. Kingdomway Company Information Table 97. Kingdomway Business Overview Table 98. Kingdomway NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Kingdomway NAD+ Enhancer Product Portfolio Table 100. Kingdomway Recent Development Table 101. Herbalmax Company Information Table 102. Herbalmax Business Overview Table 103. Herbalmax NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Herbalmax NAD+ Enhancer Product Portfolio Table 105. Herbalmax Recent Development Table 106. Genex Formulas Company Information Table 107. Genex Formulas Business Overview Table 108. Genex Formulas NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Genex Formulas NAD+ Enhancer Product Portfolio Table 110. Genex Formulas Recent Development Table 111. EZZ Company Information Table 112. EZZ Business Overview Table 113. EZZ NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. EZZ NAD+ Enhancer Product Portfolio Table 115. EZZ Recent Development Table 116. Elysium Health Company Information Table 117. Elysium Health Business Overview Table 118. Elysium Health NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Elysium Health NAD+ Enhancer Product Portfolio Table 120. Elysium Health Recent Development Table 121. Chromadex Company Information Table 122. Chromadex Business Overview Table 123. Chromadex NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Chromadex NAD+ Enhancer Product Portfolio Table 125. Chromadex Recent Development Table 126. CELFULL Company Information Table 127. CELFULL Business Overview Table 128. CELFULL NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. CELFULL NAD+ Enhancer Product Portfolio Table 130. CELFULL Recent Development Table 131. Bontac Company Information Table 132. Bontac Business Overview Table 133. Bontac NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Bontac NAD+ Enhancer Product Portfolio Table 135. Bontac Recent Development Table 136. North America NAD+ Enhancer Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 138. North America NAD+ Enhancer Sales Market Share by Country (2021-2026) Table 139. North America NAD+ Enhancer Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America NAD+ Enhancer Sales Market Share Forecast by Country (2027-2032) Table 141. North America NAD+ Enhancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America NAD+ Enhancer Market Size by Country (2021-2026) & (US$ Million) Table 143. North America NAD+ Enhancer Market Share by Country (2021-2026) Table 144. North America NAD+ Enhancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America NAD+ Enhancer Market Share Forecast by Country (2027-2032) Table 146. Europe NAD+ Enhancer Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 148. Europe NAD+ Enhancer Sales Market Share by Country (2021-2026) Table 149. Europe NAD+ Enhancer Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe NAD+ Enhancer Sales Market Share Forecast by Country (2027-2032) Table 151. Europe NAD+ Enhancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe NAD+ Enhancer Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe NAD+ Enhancer Market Share by Country (2021-2026) Table 154. Europe NAD+ Enhancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe NAD+ Enhancer Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific NAD+ Enhancer Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific NAD+ Enhancer Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific NAD+ Enhancer Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific NAD+ Enhancer Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific NAD+ Enhancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific NAD+ Enhancer Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific NAD+ Enhancer Market Share by Country (2021-2026) Table 164. Asia-Pacific NAD+ Enhancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific NAD+ Enhancer Market Share Forecast by Country (2027-2032) Table 166. Latin America NAD+ Enhancer Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 168. Latin America NAD+ Enhancer Sales Market Share by Country (2021-2026) Table 169. Latin America NAD+ Enhancer Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America NAD+ Enhancer Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America NAD+ Enhancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America NAD+ Enhancer Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America NAD+ Enhancer Market Share by Country (2021-2026) Table 174. Latin America NAD+ Enhancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America NAD+ Enhancer Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa NAD+ Enhancer Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa NAD+ Enhancer Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa NAD+ Enhancer Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa NAD+ Enhancer Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa NAD+ Enhancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa NAD+ Enhancer Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa NAD+ Enhancer Market Share by Country (2021-2026) Table 184. Middle East and Africa NAD+ Enhancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa NAD+ Enhancer Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. NAD+ Enhancer Distributors List Table 189. NAD+ Enhancer Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. NAD+ Enhancer Image Figure 2. Global NAD+ Enhancer Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NAD+ Enhancer Market Size (2021-2032) & (US$ Million) Figure 4. Global NAD+ Enhancer Sales (2021-2032) & (K Units) Figure 5. Content ＜98% Image Figure 6. Global Content ＜98% Sales YoY Growth (2021-2032) & (K Units) Figure 7. Content ≥98% Image Figure 8. Global Content ≥98% Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global NAD+ Enhancer Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global NAD+ Enhancer Market Share by Type 2025 VS 2032 Figure 11. North America NAD+ Enhancer Sales Market Share in Volume by Type in 2025 Figure 12. North America NAD+ Enhancer Sales Market Share in Value by Type in 2025 Figure 13. Europe NAD+ Enhancer Sales Market Share in Volume by Type in 2025 Figure 14. Europe NAD+ Enhancer Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific NAD+ Enhancer Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific NAD+ Enhancer Sales Market Share in Value by Type in 2025 Figure 17. Latin America NAD+ Enhancer Sales Market Share in Volume by Type in 2025 Figure 18. Latin America NAD+ Enhancer Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa NAD+ Enhancer Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa NAD+ Enhancer Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 NAD+ Enhancer Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Health Care Products Image Figure 24. Global Health Care Products Sales YoY Growth (2021-2032) & (K Units) Figure 25. ClinicsBeauty Products Image Figure 26. Global ClinicsBeauty Products Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global NAD+ Enhancer Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global NAD+ Enhancer Market Share by Application 2025 VS 2032 Figure 31. North America NAD+ Enhancer Sales Market Share in Volume by Application in 2025 Figure 32. North America NAD+ Enhancer Sales Market Share in Value by Application in 2025 Figure 33. Europe NAD+ Enhancer Sales Market Share in Volume by Application in 2025 Figure 34. Europe NAD+ Enhancer Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific NAD+ Enhancer Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific NAD+ Enhancer Sales Market Share in Value by Application in 2025 Figure 37. Latin America NAD+ Enhancer Sales Market Share in Volume by Application in 2025 Figure 38. Latin America NAD+ Enhancer Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa NAD+ Enhancer Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa NAD+ Enhancer Sales Market Share in Value by Application in 2025 Figure 41. North America NAD+ Enhancer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America NAD+ Enhancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America NAD+ Enhancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America NAD+ Enhancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe NAD+ Enhancer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe NAD+ Enhancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe NAD+ Enhancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe NAD+ Enhancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific NAD+ Enhancer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific NAD+ Enhancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific NAD+ Enhancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific NAD+ Enhancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America NAD+ Enhancer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America NAD+ Enhancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America NAD+ Enhancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America NAD+ Enhancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa NAD+ Enhancer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa NAD+ Enhancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa NAD+ Enhancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa NAD+ Enhancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. NAD+ Enhancer Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. NAD+ Enhancer Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Content ＜98%
  • Content ≥98%
Applications
  • Health Care Products
  • ClinicsBeauty Products
  • Others
Companies covered
  • EffePharm
  • Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  • GeneHarbor
  • NOMON Co., Ltd. (Teijin)
  • Maac10 Formulas
  • Kingdomway
  • Herbalmax
  • Genex Formulas
  • EZZ
  • Elysium Health
  • Chromadex
  • CELFULL
  • Bontac

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global NAD+ Enhancer Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global NAD+ Enhancer Sales Estimates and Forecasts (2021-2032)
  5. 1.3 NAD+ Enhancer Market by Type
  6. 1.3.1 Content ＜98%
  7. 1.3.2 Content ≥98%
  8. 1.4 Global NAD+ Enhancer Market Size by Type
  9. 1.4.1 Global NAD+ Enhancer Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global NAD+ Enhancer Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global NAD+ Enhancer Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America NAD+ Enhancer Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe NAD+ Enhancer Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific NAD+ Enhancer Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America NAD+ Enhancer Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa NAD+ Enhancer Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 NAD+ Enhancer Industry Trends
  2. 2.2 NAD+ Enhancer Industry Drivers
  3. 2.3 NAD+ Enhancer Industry Opportunities and Challenges
  4. 2.4 NAD+ Enhancer Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by NAD+ Enhancer Revenue (2021-2026)
  2. 3.2 Global Top Players by NAD+ Enhancer Sales (2021-2026)
  3. 3.3 Global Top Players by NAD+ Enhancer Price (2021-2026)
  4. 3.4 Global NAD+ Enhancer Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global NAD+ Enhancer Major Company Production Sites & Headquarters
  6. 3.6 Global NAD+ Enhancer Company, Product Type & Application
  7. 3.7 Global NAD+ Enhancer Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global NAD+ Enhancer Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 NAD+ Enhancer Players Market Share by Revenue in 2025
  11. 3.8.3 2025 NAD+ Enhancer Tier 1, Tier 2, and Tier 3
4 NAD+ Enhancer Regional Status and Outlook
  1. 4.1 Global NAD+ Enhancer Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global NAD+ Enhancer Historic Market Size by Region
  3. 4.2.1 Global NAD+ Enhancer Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global NAD+ Enhancer Sales in Value by Region (2021-2026)
  5. 4.2.3 Global NAD+ Enhancer Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global NAD+ Enhancer Forecasted Market Size by Region
  7. 4.3.1 Global NAD+ Enhancer Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global NAD+ Enhancer Sales in Value by Region (2027-2032)
  9. 4.3.3 Global NAD+ Enhancer Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 NAD+ Enhancer by Application
  1. 5.1 NAD+ Enhancer Market by Application
  2. 5.1.1 Health Care Products
  3. 5.1.2 ClinicsBeauty Products
  4. 5.1.3 Others
  5. 5.2 Global NAD+ Enhancer Market Size by Application
  6. 5.2.1 Global NAD+ Enhancer Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global NAD+ Enhancer Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global NAD+ Enhancer Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America NAD+ Enhancer Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe NAD+ Enhancer Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific NAD+ Enhancer Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America NAD+ Enhancer Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa NAD+ Enhancer Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 EffePharm
  2. 6.1.1 EffePharm Company Information
  3. 6.1.2 EffePharm Business Overview
  4. 6.1.3 EffePharm NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 EffePharm NAD+ Enhancer Product Portfolio
  6. 6.1.5 EffePharm Recent Developments
  7. 6.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  8. 6.2.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
  9. 6.2.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
  10. 6.2.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Portfolio
  12. 6.2.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
  13. 6.3 GeneHarbor
  14. 6.3.1 GeneHarbor Company Information
  15. 6.3.2 GeneHarbor Business Overview
  16. 6.3.3 GeneHarbor NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GeneHarbor NAD+ Enhancer Product Portfolio
  18. 6.3.5 GeneHarbor Recent Developments
  19. 6.4 NOMON Co., Ltd. (Teijin)
  20. 6.4.1 NOMON Co., Ltd. (Teijin) Company Information
  21. 6.4.2 NOMON Co., Ltd. (Teijin) Business Overview
  22. 6.4.3 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product Portfolio
  24. 6.4.5 NOMON Co., Ltd. (Teijin) Recent Developments
  25. 6.5 Maac10 Formulas
  26. 6.5.1 Maac10 Formulas Company Information
  27. 6.5.2 Maac10 Formulas Business Overview
  28. 6.5.3 Maac10 Formulas NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Maac10 Formulas NAD+ Enhancer Product Portfolio
  30. 6.5.5 Maac10 Formulas Recent Developments
  31. 6.6 Kingdomway
  32. 6.6.1 Kingdomway Company Information
  33. 6.6.2 Kingdomway Business Overview
  34. 6.6.3 Kingdomway NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kingdomway NAD+ Enhancer Product Portfolio
  36. 6.6.5 Kingdomway Recent Developments
  37. 6.7 Herbalmax
  38. 6.7.1 Herbalmax Company Information
  39. 6.7.2 Herbalmax Business Overview
  40. 6.7.3 Herbalmax NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Herbalmax NAD+ Enhancer Product Portfolio
  42. 6.7.5 Herbalmax Recent Developments
  43. 6.8 Genex Formulas
  44. 6.8.1 Genex Formulas Company Information
  45. 6.8.2 Genex Formulas Business Overview
  46. 6.8.3 Genex Formulas NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Genex Formulas NAD+ Enhancer Product Portfolio
  48. 6.8.5 Genex Formulas Recent Developments
  49. 6.9 EZZ
  50. 6.9.1 EZZ Company Information
  51. 6.9.2 EZZ Business Overview
  52. 6.9.3 EZZ NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 EZZ NAD+ Enhancer Product Portfolio
  54. 6.9.5 EZZ Recent Developments
  55. 6.10 Elysium Health
  56. 6.10.1 Elysium Health Company Information
  57. 6.10.2 Elysium Health Business Overview
  58. 6.10.3 Elysium Health NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Elysium Health NAD+ Enhancer Product Portfolio
  60. 6.10.5 Elysium Health Recent Developments
  61. 6.11 Chromadex
  62. 6.11.1 Chromadex Company Information
  63. 6.11.2 Chromadex Business Overview
  64. 6.11.3 Chromadex NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Chromadex NAD+ Enhancer Product Portfolio
  66. 6.11.5 Chromadex Recent Developments
  67. 6.12 CELFULL
  68. 6.12.1 CELFULL Company Information
  69. 6.12.2 CELFULL Business Overview
  70. 6.12.3 CELFULL NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CELFULL NAD+ Enhancer Product Portfolio
  72. 6.12.5 CELFULL Recent Developments
  73. 6.13 Bontac
  74. 6.13.1 Bontac Company Information
  75. 6.13.2 Bontac Business Overview
  76. 6.13.3 Bontac NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bontac NAD+ Enhancer Product Portfolio
  78. 6.13.5 Bontac Recent Developments
7 North America by Country
  1. 7.1 North America NAD+ Enhancer Sales by Country
  2. 7.1.1 North America NAD+ Enhancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America NAD+ Enhancer Sales by Country (2021-2026)
  4. 7.1.3 North America NAD+ Enhancer Sales Forecast by Country (2027-2032)
  5. 7.2 North America NAD+ Enhancer Market Size by Country
  6. 7.2.1 North America NAD+ Enhancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America NAD+ Enhancer Market Size by Country (2021-2026)
  8. 7.2.3 North America NAD+ Enhancer Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe NAD+ Enhancer Sales by Country
  2. 8.1.1 Europe NAD+ Enhancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe NAD+ Enhancer Sales by Country (2021-2026)
  4. 8.1.3 Europe NAD+ Enhancer Sales Forecast by Country (2027-2032)
  5. 8.2 Europe NAD+ Enhancer Market Size by Country
  6. 8.2.1 Europe NAD+ Enhancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe NAD+ Enhancer Market Size by Country (2021-2026)
  8. 8.2.3 Europe NAD+ Enhancer Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific NAD+ Enhancer Sales by Country
  2. 9.1.1 Asia-Pacific NAD+ Enhancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific NAD+ Enhancer Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific NAD+ Enhancer Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific NAD+ Enhancer Market Size by Country
  6. 9.2.1 Asia-Pacific NAD+ Enhancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific NAD+ Enhancer Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific NAD+ Enhancer Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America NAD+ Enhancer Sales by Country
  2. 10.1.1 South America NAD+ Enhancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America NAD+ Enhancer Sales by Country (2021-2026)
  4. 10.1.3 South America NAD+ Enhancer Sales Forecast by Country (2027-2032)
  5. 10.2 South America NAD+ Enhancer Market Size by Country
  6. 10.2.1 South America NAD+ Enhancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America NAD+ Enhancer Market Size by Country (2021-2026)
  8. 10.2.3 South America NAD+ Enhancer Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa NAD+ Enhancer Sales by Country
  2. 11.1.1 Middle East and Africa NAD+ Enhancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa NAD+ Enhancer Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa NAD+ Enhancer Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa NAD+ Enhancer Market Size by Country
  6. 11.2.1 Middle East and Africa NAD+ Enhancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa NAD+ Enhancer Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa NAD+ Enhancer Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 NAD+ Enhancer Value Chain Analysis
  2. 12.1.1 NAD+ Enhancer Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 NAD+ Enhancer Production Mode & Process
  7. 12.2 NAD+ Enhancer Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 NAD+ Enhancer Distributors
  10. 12.2.3 NAD+ Enhancer Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst